Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | SLC18A3 | Q16572 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sparteine SCHEMBL29352895 | 1.00 | CYP2D6 (1.00) | CYP2D6MEN1KMT2ALMNAKDM4E | |
| Sparteine SCHEMBL14029290 | 1.00 | CYP2D6 (1.00) | CYP2D6MEN1KMT2ALMNAKDM4E | |
| Sparteine SCHEMBL13646782 | 1.00 | CYP2D6 (1.00) | CYP2D6MEN1KMT2ALMNAKDM4E | |
| Sparteine SCHEMBL12573662 | 1.00 | CYP2D6 (1.00) | CYP2D6MEN1KMT2ALMNAKDM4E | |
| Sparteine SCHEMBL18468288 | 1.00 | CYP2D6 (1.00) | CYP2D6MEN1KMT2ALMNAKDM4E | |
| Sparteine SCHEMBL14331495 | 1.00 | CYP2D6 (1.00) | CYP2D6MEN1KMT2ALMNAKDM4E | |
| Sparteine SCHEMBL13531828 | 1.00 | CYP2D6 (1.00) | CYP2D6MEN1KMT2ALMNAKDM4E | |
| Sparteine SCHEMBL12301225 | 1.00 | CYP2D6 (1.00) | CYP2D6MEN1KMT2ALMNAKDM4E | |
| Sparteine SCHEMBL22619501 | 1.00 | CYP2D6 (1.00) | CYP2D6MEN1KMT2ALMNAKDM4E | |
| Sparteine SCHEMBL8913122 | 1.00 | CYP2D6 (1.00) | CYP2D6MEN1KMT2ALMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170202217-A1 | ANTIBACTERIAL POLYMER, PRODUCTION METHOD THEREFOR, AND USAGE THEREOF | NATIONAL UNIVERSITY CORPORATION YAMAGATA UNIVERSITY (JP) | 2017-07-20 | — | — | US | disclosed |
| US-8158372-B2 | Agonists of a bitter taste receptor and uses thereof | DEUTSCHES INSTITUT FÜR ERNÄHRUNGSFORSCHUNG POTSDAM-REHBRÜCKE (DE) | 2012-04-17 | — | — | US | disclosed |
| US-8158372-B2 | Agonists of a bitter taste receptor and uses thereof | DEUTSCHES INSTITUT FÜR ERNÄHRUNGSFORSCHUNG POTSDAM-REHBRÜCKE (DE) | 2012-04-17 | — | — | US | disclosed |
| US-7402670-B2 | Synthesis by chiral diamine-mediated asymmetric alkylation | JANSSEN PHARMACEUTICA, N.V. (BE) | 2008-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170202217-A1 | ANTIBACTERIAL POLYMER, PRODUCTION METHOD THEREFOR, AND USAGE THEREOF | WASF2, HASPIN, MRPL21 | CYP2D6 2414/4885MEN1 2667/4885KMT2A 2675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.